Symbols / BLCO Stock $15.78 -1.68% Bausch + Lomb Corporation
BLCO (Stock) Chart
About
Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeutic use and provide optical correction during healing. It also offers contact lens care products, eye vitamins, mineral supplements, and over-the-counter eye drops that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. The Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation operates as a subsidiary of Bausch Health Companies Inc.
Stock Fundamentals
Scroll to Statements| Market Cap | 5.62B | Enterprise Value | 10.62B | Income | -360.00M | Sales | 5.10B | Book/sh | 18.20 | Cash/sh | 1.08 |
| Dividend Yield | — | Payout | 0.00% | Employees | 13000 | IPO | — | P/E | — | Forward P/E | 14.98 |
| PEG | 0.89 | P/S | 1.10 | P/B | 0.87 | P/C | — | EV/EBITDA | 17.44 | EV/Sales | 2.08 |
| Quick Ratio | 0.84 | Current Ratio | 1.55 | Debt/Eq | 80.46 | LT Debt/Eq | — | EPS (ttm) | -1.02 | EPS next Y | 1.05 |
| EPS Growth | — | Revenue Growth | 9.80% | Earnings | 2026-04-29 | ROA | 0.85% | ROE | -5.39% | ROIC | — |
| Gross Margin | 59.81% | Oper. Margin | 11.25% | Profit Margin | -7.06% | Shs Outstand | 356.38M | Shs Float | 44.54M | Short Float | 8.06% |
| Short Ratio | 8.05 | Short Interest | — | 52W High | 18.91 | 52W Low | 10.45 | Beta | 0.65 | Avg Volume | 410.50K |
| Volume | 528.26K | Target Price | $18.35 | Recom | Hold | Prev Close | $16.05 | Price | $15.78 | Change | -1.68% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-04-06 | main | Evercore ISI Group | In-Line → In-Line | $17 |
| 2026-02-23 | main | HC Wainwright & Co. | Buy → Buy | $20 |
| 2026-02-19 | main | Citigroup | Buy → Buy | $21 |
| 2026-02-19 | main | Barclays | Equal-Weight → Equal-Weight | $20 |
| 2026-02-19 | main | Stifel | Hold → Hold | $16 |
| 2026-02-19 | main | Wells Fargo | Equal-Weight → Equal-Weight | $18 |
| 2026-02-17 | main | Stifel | Hold → Hold | $15 |
| 2026-01-05 | down | Evercore ISI Group | Outperform → In-Line | $18 |
| 2025-12-02 | up | Morgan Stanley | Equal-Weight → Overweight | $21 |
| 2025-11-14 | main | RBC Capital | Outperform → Outperform | $19 |
| 2025-11-14 | main | Wells Fargo | Equal-Weight → Equal-Weight | $17 |
| 2025-10-31 | main | Barclays | Equal-Weight → Equal-Weight | $17 |
| 2025-10-31 | main | HC Wainwright & Co. | Buy → Buy | $17 |
| 2025-10-30 | main | JP Morgan | Neutral → Neutral | $16 |
| 2025-10-30 | main | Evercore ISI Group | Outperform → Outperform | $18 |
| 2025-10-30 | main | Wells Fargo | Equal-Weight → Equal-Weight | $16 |
| 2025-10-30 | reit | Raymond James | Outperform → Outperform | $19 |
| 2025-10-07 | main | Evercore ISI Group | Outperform → Outperform | $17 |
| 2025-10-01 | init | Goldman Sachs | — → Neutral | $16 |
| 2025-08-01 | main | Morgan Stanley | Equal-Weight → Equal-Weight | $13 |
- 20 studies examine B vitamins for macular degeneration as new formula hits U.S. - Stock Titan hu, 23 Apr 2026 11
- 3 Reasons BLCO is Risky and 1 Stock to Buy Instead - Yahoo Finance hu, 26 Mar 2026 07
- Why Bausch + Lomb (BLCO) Just Strengthened Something Beyond Earnings - Insider Monkey Wed, 22 Apr 2026 06
- Discipline and Rules-Based Execution in BLCO Response - Stock Traders Daily Sun, 19 Apr 2026 20
- Bausch + Lomb targets net zero by 2050, trims lens plastic waste - Stock Titan Wed, 22 Apr 2026 11
- What Bausch + Lomb (BLCO)'s New Surgical Vision Upgrades Could Mean For Shareholders - simplywall.st Fri, 17 Apr 2026 23
- Bausch + Lomb (BLCO) Q3 2025 Earnings Transcript - The Motley Fool ue, 21 Apr 2026 17
- Is It Time To Reconsider Bausch + Lomb (BLCO) After Its 28% One-Year Rally? - Yahoo Finance Wed, 22 Apr 2026 14
- Eye Care Giant Posts $5.1 Billion in Revenue as One Investor Builds Major Position - The Motley Fool hu, 12 Mar 2026 07
- BLCO SEC Filings - Bausch + Lomb Corporation 10-K, 10-Q, 8-K Forms - Stock Titan Mon, 20 Apr 2026 16
- Is It Time To Reconsider Bausch + Lomb (BLCO) After Recent Share Price Weakness - Yahoo Finance Sun, 15 Mar 2026 07
- BLCO Stock Still 16% Below IPO — Is Silver Point’s $38.7 Million Bet a Turning Point? - The Motley Fool Wed, 03 Dec 2025 08
- Bausch + Lomb to webcast Q1 results and business update April 29 - Stock Titan Mon, 30 Mar 2026 11
- Bausch + Lomb (BLCO) Stock Is Up, What You Need To Know - Yahoo Finance Mon, 20 Oct 2025 07
- Eye surgeons get a faster retinal cutter as FDA clears Bausch + Lomb update - Stock Titan Wed, 08 Apr 2026 07
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
5,101.00
+6.47%
|
4,791.00
+15.56%
|
4,146.00
+10.03%
|
3,768.00
|
| Operating Revenue |
|
8,393.00
+12.03%
|
7,492.00
+81.36%
|
4,131.00
+10.28%
|
3,746.00
|
| Cost Of Revenue |
|
2,050.00
+9.51%
|
1,872.00
+14.01%
|
1,642.00
+8.10%
|
1,519.00
|
| Reconciled Cost Of Revenue |
|
1,887.00
+9.45%
|
1,724.00
+14.93%
|
1,500.00
+8.38%
|
1,384.00
|
| Gross Profit |
|
3,051.00
+4.52%
|
2,919.00
+16.57%
|
2,504.00
+11.34%
|
2,249.00
|
| Operating Expense |
|
2,863.00
+5.53%
|
2,713.00
+17.96%
|
2,300.00
+13.36%
|
2,029.00
|
| Research And Development |
|
371.00
+8.16%
|
343.00
+5.86%
|
324.00
+5.54%
|
307.00
|
| Selling General And Administration |
|
2,234.00
+7.30%
|
2,082.00
+19.93%
|
1,736.00
+17.46%
|
1,478.00
|
| Total Expenses |
|
4,913.00
+7.15%
|
4,585.00
+16.31%
|
3,942.00
+11.10%
|
3,548.00
|
| Operating Income |
|
188.00
-8.74%
|
206.00
+0.98%
|
204.00
-7.27%
|
220.00
|
| Total Operating Income As Reported |
|
113.00
-30.25%
|
162.00
+24.62%
|
130.00
-37.20%
|
207.00
|
| EBITDA |
|
525.00
-12.65%
|
601.00
+20.44%
|
499.00
-16.56%
|
598.00
|
| Normalized EBITDA |
|
621.00
-5.48%
|
657.00
+9.32%
|
601.00
-0.66%
|
605.00
|
| Reconciled Depreciation |
|
421.00
-3.44%
|
436.00
+14.14%
|
382.00
+0.79%
|
379.00
|
| EBIT |
|
104.00
-36.97%
|
165.00
+41.03%
|
117.00
-46.58%
|
219.00
|
| Total Unusual Items |
|
-96.00
-71.43%
|
-56.00
+45.10%
|
-102.00
-1357.14%
|
-7.00
|
| Total Unusual Items Excluding Goodwill |
|
-96.00
-71.43%
|
-56.00
+45.10%
|
-102.00
-1357.14%
|
-7.00
|
| Special Income Charges |
|
-81.00
-84.09%
|
-44.00
+40.54%
|
-74.00
-469.23%
|
-13.00
|
| Other Special Charges |
|
49.00
+113.04%
|
23.00
+666.67%
|
3.00
+50.00%
|
2.00
|
| Impairment Of Capital Assets |
|
0.00
-100.00%
|
5.00
|
0.00
-100.00%
|
1.00
|
| Restructuring And Mergern Acquisition |
|
38.00
+80.95%
|
21.00
-70.42%
|
71.00
+610.00%
|
10.00
|
| Write Off |
|
—
|
—
|
—
|
—
|
| Net Income |
|
-360.00
-13.56%
|
-317.00
-21.92%
|
-260.00
-4433.33%
|
6.00
|
| Pretax Income |
|
-317.00
-35.47%
|
-234.00
-40.96%
|
-166.00
-327.40%
|
73.00
|
| Net Non Operating Interest Income Expense |
|
-409.00
-6.51%
|
-384.00
-43.28%
|
-268.00
-91.43%
|
-140.00
|
| Interest Expense Non Operating |
|
421.00
+5.51%
|
399.00
+40.99%
|
283.00
+93.84%
|
146.00
|
| Net Interest Income |
|
-409.00
-6.51%
|
-384.00
-43.28%
|
-268.00
-91.43%
|
-140.00
|
| Interest Expense |
|
421.00
+5.51%
|
399.00
+40.99%
|
283.00
+93.84%
|
146.00
|
| Interest Income Non Operating |
|
12.00
-20.00%
|
15.00
+0.00%
|
15.00
+150.00%
|
6.00
|
| Interest Income |
|
12.00
-20.00%
|
15.00
+0.00%
|
15.00
+150.00%
|
6.00
|
| Other Income Expense |
|
-96.00
-71.43%
|
-56.00
+45.10%
|
-102.00
-1357.14%
|
-7.00
|
| Other Non Operating Income Expenses |
|
—
|
—
|
—
|
-1.00
|
| Gain On Sale Of Security |
|
-15.00
-25.00%
|
-12.00
+57.14%
|
-28.00
-566.67%
|
6.00
|
| Tax Provision |
|
35.00
-50.70%
|
71.00
-13.41%
|
82.00
+41.38%
|
58.00
|
| Tax Rate For Calcs |
|
0.00
+0.00%
|
0.00
-62.50%
|
0.00
+52.61%
|
0.00
|
| Tax Effect Of Unusual Items |
|
-14.40
-71.43%
|
-8.40
+79.41%
|
-40.80
-2123.80%
|
-1.83
|
| Net Income Including Noncontrolling Interests |
|
-352.00
-15.41%
|
-305.00
-22.98%
|
-248.00
-1753.33%
|
15.00
|
| Net Income From Continuing Operation Net Minority Interest |
|
-360.00
-13.56%
|
-317.00
-21.92%
|
-260.00
-4433.33%
|
6.00
|
| Net Income From Continuing And Discontinued Operation |
|
-360.00
-13.56%
|
-317.00
-21.92%
|
-260.00
-4433.33%
|
6.00
|
| Net Income Continuous Operations |
|
-352.00
-15.41%
|
-305.00
-22.98%
|
-248.00
-1753.33%
|
15.00
|
| Minority Interests |
|
-8.00
+33.33%
|
-12.00
+0.00%
|
-12.00
-33.33%
|
-9.00
|
| Normalized Income |
|
-278.40
-3.34%
|
-269.40
-35.51%
|
-198.80
-1880.52%
|
11.17
|
| Net Income Common Stockholders |
|
-360.00
-13.56%
|
-317.00
-21.92%
|
-260.00
-4433.33%
|
6.00
|
| Diluted EPS |
|
—
|
-0.90
-21.62%
|
-0.74
-3800.00%
|
0.02
|
| Basic EPS |
|
—
|
-0.90
-21.62%
|
-0.74
-3800.00%
|
0.02
|
| Basic Average Shares |
|
—
|
351.80
+0.37%
|
350.50
+0.14%
|
350.00
|
| Diluted Average Shares |
|
—
|
351.80
+0.37%
|
350.50
+0.14%
|
350.00
|
| Diluted NI Availto Com Stockholders |
|
-360.00
-13.56%
|
-317.00
-21.92%
|
-260.00
-4433.33%
|
6.00
|
| Amortization |
|
258.00
-10.42%
|
288.00
+20.00%
|
240.00
-1.64%
|
244.00
|
| Amortization Of Intangibles Income Statement |
|
258.00
-10.42%
|
288.00
+20.00%
|
240.00
-1.64%
|
244.00
|
| Depreciation Amortization Depletion Income Statement |
|
258.00
-10.42%
|
288.00
+20.00%
|
240.00
-1.64%
|
244.00
|
| Depreciation And Amortization In Income Statement |
|
258.00
-10.42%
|
288.00
+20.00%
|
240.00
-1.64%
|
244.00
|
| Gain On Sale Of PPE |
|
6.00
+20.00%
|
5.00
|
0.00
|
0.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
14,022.00
+4.11%
|
13,469.00
+0.20%
|
13,442.00
+20.62%
|
11,144.00
|
| Current Assets |
|
2,977.00
+6.78%
|
2,788.00
+1.68%
|
2,742.00
+28.31%
|
2,137.00
|
| Cash Cash Equivalents And Short Term Investments |
|
383.00
+25.57%
|
305.00
-7.85%
|
331.00
-6.50%
|
354.00
|
| Cash And Cash Equivalents |
|
383.00
+25.57%
|
305.00
-7.85%
|
331.00
-6.50%
|
354.00
|
| Receivables |
|
1,221.00
+19.01%
|
1,026.00
+22.29%
|
839.00
+15.88%
|
724.00
|
| Accounts Receivable |
|
1,221.00
+19.01%
|
1,026.00
+22.29%
|
839.00
+15.88%
|
724.00
|
| Gross Accounts Receivable |
|
1,238.00
+18.58%
|
1,044.00
+21.40%
|
860.00
+15.28%
|
746.00
|
| Allowance For Doubtful Accounts Receivable |
|
-17.00
+5.56%
|
-18.00
+14.29%
|
-21.00
+4.55%
|
-22.00
|
| Inventory |
|
976.00
-5.79%
|
1,036.00
+0.78%
|
1,028.00
+63.69%
|
628.00
|
| Raw Materials |
|
243.00
-7.25%
|
262.00
+0.38%
|
261.00
+60.12%
|
163.00
|
| Work In Process |
|
98.00
-1.01%
|
99.00
-1.00%
|
100.00
+127.27%
|
44.00
|
| Finished Goods |
|
635.00
-5.93%
|
675.00
+1.20%
|
667.00
+58.43%
|
421.00
|
| Prepaid Assets |
|
—
|
—
|
—
|
405.00
|
| Restricted Cash |
|
14.00
+27.27%
|
11.00
+266.67%
|
3.00
-88.46%
|
26.00
|
| Other Current Assets |
|
383.00
-6.59%
|
410.00
-24.21%
|
541.00
+33.58%
|
405.00
|
| Total Non Current Assets |
|
11,045.00
+3.41%
|
10,681.00
-0.18%
|
10,700.00
+18.80%
|
9,007.00
|
| Net PPE |
|
1,762.00
+18.65%
|
1,485.00
+6.83%
|
1,390.00
+6.92%
|
1,300.00
|
| Gross PPE |
|
3,658.00
+15.43%
|
3,169.00
+4.93%
|
3,020.00
+7.28%
|
2,815.00
|
| Accumulated Depreciation |
|
-1,896.00
-12.59%
|
-1,684.00
-3.31%
|
-1,630.00
-7.59%
|
-1,515.00
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Land And Improvements |
|
47.00
+9.30%
|
43.00
-4.44%
|
45.00
+2.27%
|
44.00
|
| Buildings And Improvements |
|
743.00
+17.56%
|
632.00
+1.28%
|
624.00
+1.63%
|
614.00
|
| Machinery Furniture Equipment |
|
1,943.00
+16.07%
|
1,674.00
+1.03%
|
1,657.00
+4.54%
|
1,585.00
|
| Construction In Progress |
|
525.00
+14.63%
|
458.00
+31.99%
|
347.00
+46.41%
|
237.00
|
| Other Properties |
|
—
|
—
|
—
|
335.00
|
| Leases |
|
400.00
+10.50%
|
362.00
+4.32%
|
347.00
+3.58%
|
335.00
|
| Goodwill And Other Intangible Assets |
|
8,039.00
+0.27%
|
8,017.00
-1.80%
|
8,164.00
+24.36%
|
6,565.00
|
| Goodwill |
|
4,758.00
+5.20%
|
4,523.00
-1.14%
|
4,575.00
+1.51%
|
4,507.00
|
| Other Intangible Assets |
|
3,281.00
-6.10%
|
3,494.00
-2.65%
|
3,589.00
+74.39%
|
2,058.00
|
| Non Current Deferred Assets |
|
934.00
+5.54%
|
885.00
-3.91%
|
921.00
-0.65%
|
927.00
|
| Non Current Deferred Taxes Assets |
|
934.00
+5.54%
|
885.00
-3.91%
|
921.00
-0.65%
|
927.00
|
| Other Non Current Assets |
|
310.00
+5.44%
|
294.00
+30.67%
|
225.00
+4.65%
|
215.00
|
| Total Liabilities Net Minority Interest |
|
7,503.00
+8.35%
|
6,925.00
+6.18%
|
6,522.00
+61.32%
|
4,043.00
|
| Current Liabilities |
|
1,920.00
+10.47%
|
1,738.00
+10.07%
|
1,579.00
+21.84%
|
1,296.00
|
| Payables And Accrued Expenses |
|
1,144.00
+9.89%
|
1,041.00
+13.65%
|
916.00
+24.97%
|
733.00
|
| Payables |
|
388.00
-0.26%
|
389.00
-25.48%
|
522.00
+41.08%
|
370.00
|
| Accounts Payable |
|
388.00
-0.26%
|
389.00
-25.48%
|
522.00
+41.08%
|
370.00
|
| Current Accrued Expenses |
|
756.00
+15.95%
|
652.00
+65.48%
|
394.00
+8.54%
|
363.00
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
250.00
+8.70%
|
230.00
-1.29%
|
233.00
+18.88%
|
196.00
|
| Current Debt And Capital Lease Obligation |
|
39.00
-2.50%
|
40.00
+33.33%
|
30.00
+20.00%
|
25.00
|
| Current Debt |
|
39.00
-2.50%
|
40.00
+33.33%
|
30.00
+20.00%
|
25.00
|
| Other Current Borrowings |
|
—
|
—
|
—
|
25.00
|
| Other Current Liabilities |
|
487.00
+14.05%
|
427.00
+6.75%
|
400.00
+16.96%
|
342.00
|
| Total Non Current Liabilities Net Minority Interest |
|
5,583.00
+7.63%
|
5,187.00
+4.94%
|
4,943.00
+79.94%
|
2,747.00
|
| Long Term Debt And Capital Lease Obligation |
|
5,043.00
+6.30%
|
4,744.00
+4.68%
|
4,532.00
+87.97%
|
2,411.00
|
| Long Term Debt |
|
5,043.00
+6.30%
|
4,744.00
+4.68%
|
4,532.00
+87.97%
|
2,411.00
|
| Non Current Deferred Liabilities |
|
19.00
+46.15%
|
13.00
-7.14%
|
14.00
+100.00%
|
7.00
|
| Non Current Deferred Taxes Liabilities |
|
19.00
+46.15%
|
13.00
-7.14%
|
14.00
+100.00%
|
7.00
|
| Other Non Current Liabilities |
|
521.00
+21.16%
|
430.00
+8.31%
|
397.00
+20.67%
|
329.00
|
| Stockholders Equity |
|
6,448.00
-0.39%
|
6,473.00
-5.50%
|
6,850.00
-2.60%
|
7,033.00
|
| Common Stock Equity |
|
6,448.00
-0.39%
|
6,473.00
-5.50%
|
6,850.00
-2.60%
|
7,033.00
|
| Capital Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Common Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
354.21
+0.51%
|
352.40
+0.42%
|
350.91
+0.26%
|
350.00
|
| Ordinary Shares Number |
|
354.21
+0.51%
|
352.40
+0.42%
|
350.91
+0.26%
|
350.00
|
| Additional Paid In Capital |
|
8,563.00
+1.59%
|
8,429.00
+0.96%
|
8,349.00
+0.77%
|
8,285.00
|
| Retained Earnings |
|
-931.00
-63.05%
|
-571.00
-124.80%
|
-254.00
-4333.33%
|
6.00
|
| Gains Losses Not Affecting Retained Earnings |
|
-1,184.00
+14.51%
|
-1,385.00
-11.24%
|
-1,245.00
+1.03%
|
-1,258.00
|
| Minority Interest |
|
71.00
+0.00%
|
71.00
+1.43%
|
70.00
+2.94%
|
68.00
|
| Other Equity Adjustments |
|
-1,184.00
+14.51%
|
-1,385.00
-11.24%
|
-1,245.00
+1.03%
|
-1,258.00
|
| Total Equity Gross Minority Interest |
|
6,519.00
-0.38%
|
6,544.00
-5.43%
|
6,920.00
-2.55%
|
7,101.00
|
| Total Capitalization |
|
11,491.00
+2.44%
|
11,217.00
-1.45%
|
11,382.00
+20.52%
|
9,444.00
|
| Working Capital |
|
1,057.00
+0.67%
|
1,050.00
-9.72%
|
1,163.00
+38.29%
|
841.00
|
| Invested Capital |
|
11,530.00
+2.43%
|
11,257.00
-1.36%
|
11,412.00
+20.52%
|
9,469.00
|
| Total Debt |
|
5,082.00
+6.23%
|
4,784.00
+4.87%
|
4,562.00
+87.27%
|
2,436.00
|
| Net Debt |
|
4,699.00
+4.91%
|
4,479.00
+5.86%
|
4,231.00
+103.22%
|
2,082.00
|
| Net Tangible Assets |
|
-1,591.00
-3.04%
|
-1,544.00
-17.50%
|
-1,314.00
-380.77%
|
468.00
|
| Tangible Book Value |
|
-1,591.00
-3.04%
|
-1,544.00
-17.50%
|
-1,314.00
-380.77%
|
468.00
|
| Current Provisions |
|
—
|
—
|
—
|
85.00
|
| Interest Payable |
|
57.00
+62.86%
|
35.00
|
—
|
—
|
| Line Of Credit |
|
—
|
—
|
—
|
0.00
|
| Other Equity Interest |
|
—
|
—
|
—
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
283.00
+21.98%
|
232.00
+1464.71%
|
-17.00
-104.93%
|
345.00
|
| Cash Flow From Continuing Operating Activities |
|
283.00
+21.98%
|
232.00
+1464.71%
|
-17.00
-104.93%
|
345.00
|
| Net Income From Continuing Operations |
|
-352.00
-15.41%
|
-305.00
-22.98%
|
-248.00
-1753.33%
|
15.00
|
| Depreciation Amortization Depletion |
|
421.00
-3.44%
|
436.00
+14.14%
|
382.00
+0.79%
|
379.00
|
| Amortization Cash Flow |
|
—
|
—
|
382.00
+0.79%
|
379.00
|
| Depreciation And Amortization |
|
421.00
-3.44%
|
436.00
+14.14%
|
382.00
+0.79%
|
379.00
|
| Amortization Of Intangibles |
|
—
|
—
|
382.00
+0.79%
|
379.00
|
| Other Non Cash Items |
|
56.00
-32.53%
|
83.00
+59.62%
|
52.00
+446.67%
|
-15.00
|
| Stock Based Compensation |
|
149.00
+61.96%
|
92.00
+24.32%
|
74.00
+19.35%
|
62.00
|
| Provisionand Write Offof Assets |
|
31.00
+19.23%
|
26.00
+23.81%
|
21.00
-16.00%
|
25.00
|
| Asset Impairment Charge |
|
0.00
-100.00%
|
5.00
|
0.00
-100.00%
|
1.00
|
| Deferred Tax |
|
-32.00
-220.00%
|
-10.00
+0.00%
|
-10.00
+88.89%
|
-90.00
|
| Deferred Income Tax |
|
-32.00
-220.00%
|
-10.00
+0.00%
|
-10.00
+88.89%
|
-90.00
|
| Operating Gains Losses |
|
-8.00
+0.00%
|
-8.00
-700.00%
|
-1.00
+92.31%
|
-13.00
|
| Gain Loss On Investment Securities |
|
-10.00
+23.08%
|
-13.00
+0.00%
|
-13.00
-116.67%
|
-6.00
|
| Net Foreign Currency Exchange Gain Loss |
|
2.00
-80.00%
|
10.00
-16.67%
|
12.00
+271.43%
|
-7.00
|
| Change In Working Capital |
|
18.00
+120.69%
|
-87.00
+69.69%
|
-287.00
-1410.53%
|
-19.00
|
| Change In Receivables |
|
-148.00
+34.80%
|
-227.00
-87.60%
|
-121.00
-27.37%
|
-95.00
|
| Changes In Account Receivables |
|
-148.00
+34.80%
|
-227.00
-87.60%
|
-121.00
-27.37%
|
-95.00
|
| Change In Inventory |
|
38.00
+125.85%
|
-147.00
+44.32%
|
-264.00
-149.06%
|
-106.00
|
| Change In Prepaid Assets |
|
20.00
-87.58%
|
161.00
+209.52%
|
-147.00
-2000.00%
|
-7.00
|
| Change In Payables And Accrued Expense |
|
108.00
-14.29%
|
126.00
-48.57%
|
245.00
+29.63%
|
189.00
|
| Change In Payable |
|
108.00
-14.29%
|
126.00
-48.57%
|
245.00
+29.63%
|
189.00
|
| Change In Account Payable |
|
108.00
-14.29%
|
126.00
-48.57%
|
245.00
+29.63%
|
189.00
|
| Investing Cash Flow |
|
-455.00
-10.44%
|
-412.00
+80.46%
|
-2,109.00
-880.93%
|
-215.00
|
| Cash Flow From Continuing Investing Activities |
|
-455.00
-10.44%
|
-412.00
+80.46%
|
-2,109.00
-880.93%
|
-215.00
|
| Net PPE Purchase And Sale |
|
-349.00
-19.93%
|
-291.00
-60.77%
|
-181.00
-3.43%
|
-175.00
|
| Purchase Of PPE |
|
-349.00
-19.93%
|
-291.00
-60.77%
|
-181.00
-3.43%
|
-175.00
|
| Capital Expenditure |
|
-349.00
-19.93%
|
-291.00
-60.77%
|
-181.00
-3.43%
|
-175.00
|
| Net Investment Purchase And Sale |
|
-3.00
-250.00%
|
2.00
+300.00%
|
-1.00
-120.00%
|
5.00
|
| Purchase Of Investment |
|
-11.00
+8.33%
|
-12.00
+29.41%
|
-17.00
+0.00%
|
-17.00
|
| Sale Of Investment |
|
8.00
-42.86%
|
14.00
-12.50%
|
16.00
-27.27%
|
22.00
|
| Net Business Purchase And Sale |
|
-122.00
+11.59%
|
-138.00
+92.89%
|
-1,941.00
-4213.33%
|
-45.00
|
| Purchase Of Business |
|
-122.00
+11.59%
|
-138.00
+92.89%
|
-1,941.00
-4213.33%
|
-45.00
|
| Net Intangibles Purchase And Sale |
|
—
|
—
|
—
|
0.00
|
| Purchase Of Intangibles |
|
—
|
—
|
—
|
0.00
|
| Net Other Investing Changes |
|
7.00
+250.00%
|
2.00
+100.00%
|
1.00
|
—
|
| Financing Cash Flow |
|
225.00
+26.40%
|
178.00
-91.43%
|
2,078.00
+2465.43%
|
81.00
|
| Cash Flow From Continuing Financing Activities |
|
225.00
+26.40%
|
178.00
-91.43%
|
2,078.00
+2465.43%
|
81.00
|
| Net Issuance Payments Of Debt |
|
261.00
+29.85%
|
201.00
-90.50%
|
2,115.00
-13.95%
|
2,458.00
|
| Issuance Of Debt |
|
3,357.00
+432.01%
|
631.00
-72.28%
|
2,276.00
-7.89%
|
2,471.00
|
| Repayment Of Debt |
|
-3,096.00
-620.00%
|
-430.00
-167.08%
|
-161.00
-1138.46%
|
-13.00
|
| Long Term Debt Issuance |
|
3,357.00
+432.01%
|
631.00
-72.28%
|
2,276.00
-7.89%
|
2,471.00
|
| Long Term Debt Payments |
|
-3,096.00
-620.00%
|
-430.00
-167.08%
|
-161.00
-1138.46%
|
-13.00
|
| Net Long Term Debt Issuance |
|
261.00
+29.85%
|
201.00
-90.50%
|
2,115.00
-13.95%
|
2,458.00
|
| Net Other Financing Charges |
|
-36.00
-56.52%
|
-23.00
+37.84%
|
-37.00
+98.44%
|
-2,377.00
|
| Changes In Cash |
|
53.00
+2750.00%
|
-2.00
+95.83%
|
-48.00
-122.75%
|
211.00
|
| Effect Of Exchange Rate Changes |
|
28.00
+275.00%
|
-16.00
-900.00%
|
2.00
+125.00%
|
-8.00
|
| Beginning Cash Position |
|
316.00
-5.39%
|
334.00
-12.11%
|
380.00
+114.69%
|
177.00
|
| End Cash Position |
|
397.00
+25.63%
|
316.00
-5.39%
|
334.00
-12.11%
|
380.00
|
| Free Cash Flow |
|
-66.00
-11.86%
|
-59.00
+70.20%
|
-198.00
-216.47%
|
170.00
|
| Interest Paid Supplemental Data |
|
380.00
-8.43%
|
415.00
+74.37%
|
238.00
+80.30%
|
132.00
|
| Income Tax Paid Supplemental Data |
|
59.00
-35.16%
|
91.00
+42.19%
|
64.00
-22.89%
|
83.00
|
| Interest Received CFI |
|
12.00
-7.69%
|
13.00
+0.00%
|
13.00
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-03-10 View
- 42026-03-10 View
- 42026-03-10 View
- 42026-03-04 View
- 42026-03-03 View
- 42026-03-03 View
- 42026-03-02 View
- 42026-03-02 View
- 42026-03-02 View
- 42026-03-02 View
- 42026-03-02 View
- 42026-03-02 View
- 42026-03-02 View
- 42026-02-27 View
- 42026-02-27 View
- 42026-02-27 View
- 42026-02-27 View
- 42026-02-27 View
- 42026-02-27 View
- 42026-02-27 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|